Dosing regimen for an old cancer drug shows new promise as an immunotherapy
As cancer cells progress, they accumulate hundreds and even thousands of genetic and epigenetic chan...
Researchers influence CDC’s clarification on prescribing opioids for cancer pain
To reduce the number of people who may misuse, abu...
Lower rates of opioid prescriptions in states that implemented medical cannabis use laws
Using data from privately-insured adults, new find...
FDA approves first drug to help tame cluster headaches
(HealthDay)— The U.S. Food and Drug Administrati...
FDA approves first gene therapy for spinal muscular atrophy
(HealthDay)—The first gene therapy has been appr...
Doping soldiers so they fight better—is it ethical?
The military is constantly using technology to bui...
Molecular basis of brain dysfunction and embryo malformation associated with thalidomide
In the late 1950s, thalidomide was prescribed as a...
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) ...
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) &#...
Insurers’ denials of opioid coverage spurs CDC to clarify guidelines
(HealthDay)—People with severe pain from cancer ...
